e-Therapeutics plc TR-1: Notification of Major Interest in Shares (0526H)
02 June 2017 - 11:51PM
UK Regulatory
TIDMETX
RNS Number : 0526H
e-Therapeutics plc
02 June 2017
For filings with the FSA
include the annex
For filings with issuer exclude
the annex
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
----------------------------------------------------------------------------------------------------------------------
1. Identity of the issuer or E Therapeutics Plc
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
--------------------------------------------------------------- -----------------------------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
----------------------------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights X
------------------------------------------------------------------ --------------------------------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
------------------------------------------------------------------ --------------------------------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
------------------------------------------------------------------ --------------------------------------------------
An event changing the breakdown of voting rights
------------------------------------------------------------------ --------------------------------------------------
Other (please
specify):
--------------------------------------------------------- ------- --------------------------------------------------
3. Full name of person(s) Richard Griffiths and controlled
subject to the undertakings
notification obligation:
(iii)
----------------------------------------------------------- ---------------------------------------------------------
4. Full name of shareholder(s)
(if different from 3.):(iv)
----------------------------------------------------------- ---------------------------------------------------------
5. Date of the transaction 1 June 2017
and date on
which the threshold is
crossed or
reached: (v)
----------------------------------------------------------- ---------------------------------------------------------
6. Date on which issuer 2 June 2017
notified:
----------------------------------------------------------- ---------------------------------------------------------
7. Threshold(s) that is/are > 3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20%
crossed or
reached: (vi, vii)
----------------------------------------------------------- ---------------------------------------------------------
8. Notified details:
----------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
----------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
------------- -------------------------------- ---------------------------------------------------------------------
Number Number Number Number of % of voting
of of of shares voting rights (x)
Shares Voting rights
Rights
------------- --------------- --------------- ------------- --------------------------- -------------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
------------- ----------- ----------- ------------- ------------- ------------ ------------ -----------
Ordinary
GB00B2823H99 < 3% < 3% 54,000,000 54,000,000 20.12%
------------- --------------- --------------- ------------- ------------- ------------ ------------ -----------
B: Qualifying Financial Instruments
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument (xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
----------------- ------------- ------------------------------ ----------------------------- ---------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights instrument rights (xix,
instrument (xvii) period refers to xx)
(xviii)
--------------- ------------- ------------- --------------- ----------------------------- -----------------------
Nominal Delta
--------------- ------------- ------------- --------------- ----------------------------- ------------ ---------
Total (A+B+C)
----------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------------------------------- -------------------------------------------------------------------
54,000,000 20.12%
------------------------------------------------- -------------------------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
-------------------------------------------------------------------------------
Oak Trust Limited 1,500,000
Richard Griffiths 52,500,000
Total 54,000,000
-----------
The above entities are controlled by Richard Griffiths
Proxy Voting:
-------------------------------------------------------------------------------
10. Name of the proxy holder:
------------------------------------------------------------- ----------------
11. Number of voting rights proxy
holder will cease
to hold:
------------------------------------------------------------- ----------------
12. Date on which proxy holder will
cease to hold
voting rights:
------------------------------------------------------------- ----------------
13. Additional information:
------------------------------------------------------------- ----------------
14. Contact name: James Sutcliffe
------------------------------------------------------------- ----------------
15. Contact telephone number: +44 1534 719761
------------------------------------------------------------- ----------------
Note: Annex should only be submitted to the FCA not
the issuer
Annex: Notification of major interests in share
A: Identity of the persons or legal entity subject to
the notification obligation
--------------------------------------------------------
Full name
(including legal form of
legal entities)
------------------------------------------------------
Contact address
(registered office for legal
entities)
------------------------------------------------------
Phone number & email
------------------------------------------------------
Other useful information
(at least legal representative
for legal persons)
------------------------------------------------------
B: Identity of the notifier, if applicable
--------------------------------------------------------
Full name
------------------------------------------------------
Contact address
------------------------------------------------------
Phone number & email
------------------------------------------------------
Other useful information
(e.g. functional relationship
with the person or legal
entity subject to the notification
obligation)
------------------------------------------------------
C: Additional information
--------------------------------------------------------
For notes on how to complete form TR-1 please see the
FCA website.
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLLLFSVRDIFIID
(END) Dow Jones Newswires
June 02, 2017 09:51 ET (13:51 GMT)
E-therapeutics (LSE:ETX)
Historical Stock Chart
From Apr 2024 to May 2024
E-therapeutics (LSE:ETX)
Historical Stock Chart
From May 2023 to May 2024